We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.1B
AUM Growth
-$32.7M
Cap. Flow
-$129M
Cap. Flow %
-1.28%
Top 10 Hldgs %
46.32%
Holding
595
New
41
Increased
67
Reduced
176
Closed
32

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$19.8M
2
HDB icon
HDFC Bank
HDB
+$13.2M
3
FISV
Fiserv Inc
FISV
+$10.3M
4
PYPL icon
PayPal
PYPL
+$9.75M
5
MSFT icon
Microsoft
MSFT
+$9.65M

Sector Composition

Rank Sector Weight
1 Technology 38.51%
2 Healthcare 17.03%
3 Consumer Discretionary 10.46%
4 Financials 10.36%
5 Communication Services 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
251
L3Harris
LHX
$53.9B
$264K ﹤0.01%
1,268
+28
+2% +$5.88K
COKE icon
252
Coca-Cola Consolidated
COKE
$12.6B
$259K ﹤0.01%
3,120
VB icon
253
Vanguard Morningstar Small-Cap ETF
VB
$83.2B
$257K ﹤0.01%
1,205
-12
-1% -$2.58K
MGY icon
254
Magnolia Oil & Gas
MGY
$6.12B
$257K ﹤0.01%
10,000
LAMR icon
255
Lamar Advertising Co
LAMR
$15.8B
$247K ﹤0.01%
2,175
BTU icon
256
Peabody Energy
BTU
$3B
$239K ﹤0.01%
10,000
BSM icon
257
Black Stone Minerals
BSM
$3.04B
$234K ﹤0.01%
15,000
OKE icon
258
Oneok
OKE
$58.3B
$233K ﹤0.01%
2,915
SO icon
259
Southern Company
SO
$106B
$226K ﹤0.01%
3,096
-5
-0.2% -$345
MTCH icon
260
Match Group
MTCH
$8.42B
$224K ﹤0.01%
7,000
VRTX icon
261
Vertex Pharmaceuticals
VRTX
$133B
$224K ﹤0.01%
559
+12
+2% +$5.07K
VGSH icon
262
Vanguard Short-Term Treasury ETF
VGSH
$30.3B
$223K ﹤0.01%
3,872
ANET icon
263
Arista Networks
ANET
$262B
$223K ﹤0.01%
3,628
MCHP icon
264
Microchip Technology
MCHP
$43.4B
$221K ﹤0.01%
2,642
GEHC icon
265
GE HealthCare
GEHC
$33.1B
$220K ﹤0.01%
2,610
-300
-10% -$25K
ED icon
266
Consolidated Edison
ED
$39.9B
$218K ﹤0.01%
2,350
AUB icon
267
Atlantic Union Bankshares
AUB
$6.11B
$217K ﹤0.01%
6,473
TDG icon
268
TransDigm Group
TDG
$67.4B
$216K ﹤0.01%
180
CSX icon
269
CSX Corp
CSX
$93.5B
$212K ﹤0.01%
6,134
IJJ icon
270
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.06B
$210K ﹤0.01%
1,885
-220
-10% -$24.8K
IWV icon
271
iShares Russell 3000 ETF
IWV
$20.6B
$207K ﹤0.01%
725
ANSS
272
DELISTED
Ansys
ANSS
$204K ﹤0.01%
627
DVN icon
273
Devon Energy
DVN
$48.5B
$200K ﹤0.01%
3,835
CC icon
274
Chemours
CC
$2.28B
$199K ﹤0.01%
7,547
-615
-8% -$17.5K
GUNR icon
275
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.01B
$199K ﹤0.01%
4,789
+360
+8% +$14.1K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Loring Wolcott & Coolidge Fiduciary Advisors held 595 positions worth $10.1B, down 0.32% from $10.1B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 filing shows 41 new, 67 increased, 176 reduced and 32 closed positions. Its largest new stake was GE Vernova: 3,494 shares worth $478K. The largest sale was Mastercard, an estimated $19.8M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2024 buy was GE Vernova: 3,494 shares worth $478K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Regeneron Pharmaceuticals in Q1 2024, an estimated $24.6M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2024 reduction was Mastercard, cutting an estimated $19.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Wheaton Precious Metals in Q1 2024, selling an estimated $497K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 46% of its $10.1B portfolio in Q1 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 41 new positions and closed 32 in Q1 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 0.32% quarter-over-quarter to $10.1B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.